Podcast: When a Harvard Alum is the CEO of Moderna Therapeutics, in the Race for the COVID-19 Vaccine



In this podcast episode, Harvard Alumni Entrepreneurs President Denise Silber, host of HAE Invites, interviews Harvard alum Stéphane Bancel, the CEO of Moderna Therapeutics (MRNA), one of the most strategic and observed life science companies of the COVID crisis. In December 2018, Moderna became the largest biotech IPO in history. Now in 2020, they are called upon to do what has never been done before, to accelerate the development of a vaccine for a new disease. Join Denise as she speaks with Stéphane Bancel, the founding CEO of this Cambridge, MA research-based firm, whose pioneering messenger RNA (mRNA) technology platform, includes a leading COVID-19 vaccine candidate.